O	0	9	Molecular	Molecular	JJ	B-NP
O	10	16	events	event	NNS	I-NP
O	17	24	leading	lead	VBG	B-VP
O	25	27	to	to	TO	B-PP
O	28	36	enhanced	enhance	VBN	B-NP
O	37	44	glucose	glucose	NN	I-NP
O	45	54	transport	transport	NN	I-NP
O	55	57	in	in	IN	B-PP
O	58	62	Rous	Rous	NNP	B-NP
O	63	70	sarcoma	sarcoma	NN	I-NP
O	71	76	virus	virus	NN	I-NP
O	76	77	-	-	HYPH	B-NP
O	77	88	transformed	transform	VBN	I-NP
B-Cell	89	94	cells	cell	NNS	I-NP
O	94	95	.	.	.	O

O	97	111	Transformation	Transformation	NN	B-NP
O	112	114	by	by	IN	B-PP
O	115	119	Rous	Rous	NNP	B-NP
O	120	127	sarcoma	sarcoma	NN	I-NP
O	128	133	virus	virus	NN	I-NP
O	134	141	results	result	VBZ	B-VP
O	142	144	in	in	IN	B-PP
O	145	146	a	a	DT	B-NP
O	147	155	dramatic	dramatic	JJ	I-NP
O	156	164	increase	increase	NN	I-NP
O	165	167	in	in	IN	B-PP
O	168	171	the	the	DT	B-NP
O	172	176	rate	rate	NN	I-NP
O	177	179	at	at	IN	B-PP
O	180	185	which	which	WDT	B-NP
O	186	189	the	the	DT	B-NP
O	190	201	transformed	transform	VBN	I-NP
B-Cell	202	207	cells	cell	NNS	I-NP
O	208	217	transport	transport	VBP	B-VP
O	218	225	glucose	glucose	NN	B-NP
O	226	232	across	across	IN	B-PP
O	233	236	the	the	DT	B-NP
B-Cellular_component	237	241	cell	cell	NN	I-NP
I-Cellular_component	242	250	membrane	membrane	NN	I-NP
O	250	251	.	.	.	O

O	252	255	The	The	DT	B-NP
O	256	265	increased	increase	VBN	I-NP
O	266	275	transport	transport	NN	I-NP
O	276	280	rate	rate	NN	I-NP
O	281	283	is	be	VBZ	B-VP
O	284	285	a	a	DT	B-NP
O	286	297	consequence	consequence	NN	I-NP
O	298	300	of	of	IN	B-PP
O	301	303	an	an	DT	B-NP
O	304	313	increased	increase	VBN	I-NP
O	314	320	number	number	NN	I-NP
O	321	323	of	of	IN	B-PP
O	324	336	transporters	transporter	NNS	B-NP
O	337	339	in	in	IN	B-PP
O	340	343	the	the	DT	B-NP
O	344	355	transformed	transform	VBN	I-NP
B-Cell	356	361	cells	cell	NNS	I-NP
O	361	362	.	.	.	O

O	363	372	Utilizing	Utilize	VBG	B-VP
O	373	381	antibody	antibody	NN	B-NP
O	382	388	raised	raise	VBN	B-VP
O	389	396	against	against	IN	B-PP
O	397	400	the	the	DT	B-NP
O	401	409	purified	purify	VBN	I-NP
O	410	415	human	human	JJ	I-NP
B-Cell	416	427	erythrocyte	erythrocyte	NN	I-NP
O	428	435	glucose	glucose	NN	I-NP
O	436	447	transporter	transporter	NN	I-NP
O	447	448	,	,	,	O
O	449	451	we	we	PRP	B-NP
O	452	456	have	have	VBP	B-VP
O	457	467	identified	identify	VBN	I-VP
O	468	471	the	the	DT	B-NP
O	472	479	glucose	glucose	NN	I-NP
O	480	491	transporter	transporter	NN	I-NP
O	492	494	as	as	IN	B-PP
O	495	496	a	a	DT	B-NP
B-Cellular_component	497	505	membrane	membrane	NN	I-NP
O	506	518	glycoprotein	glycoprotein	NN	I-NP
O	519	523	with	with	IN	B-PP
O	524	525	a	a	DT	B-NP
O	526	533	monomer	monomer	NN	I-NP
O	534	536	Mr	Mr	NN	I-NP
O	537	539	of	of	IN	B-PP
O	540	553	approximately	approximately	RB	B-NP
O	554	556	41	41	CD	I-NP
O	556	557	,	,	,	I-NP
O	557	560	000	000	CD	I-NP
O	560	561	.	.	.	O

O	562	565	The	The	DT	B-NP
O	566	575	increased	increase	VBN	I-NP
O	576	580	rate	rate	NN	I-NP
O	581	583	of	of	IN	B-PP
O	584	591	glucose	glucose	NN	B-NP
O	592	601	transport	transport	NN	I-NP
O	602	604	is	be	VBZ	B-VP
O	605	614	dependent	dependent	JJ	B-ADJP
O	615	617	on	on	IN	B-PP
O	618	621	the	the	DT	B-NP
O	622	630	activity	activity	NN	I-NP
O	631	633	of	of	IN	B-PP
O	634	641	pp60src	pp60src	NN	B-NP
O	641	642	,	,	,	O
O	643	646	the	the	DT	B-NP
O	647	659	transforming	transform	VBG	I-NP
O	660	667	protein	protein	NN	I-NP
O	668	670	of	of	IN	B-PP
O	671	675	Rous	Rous	NNP	B-NP
O	676	683	sarcoma	sarcoma	NN	I-NP
O	684	689	virus	virus	NN	I-NP
O	689	690	.	.	.	O

O	691	695	This	This	DT	B-NP
O	696	703	protein	protein	NN	I-NP
O	704	707	has	have	VBZ	B-VP
O	708	712	been	be	VBN	I-VP
O	713	718	shown	show	VBN	I-VP
O	719	721	to	to	TO	I-VP
O	722	724	be	be	VB	I-VP
O	725	726	a	a	DT	B-NP
O	727	734	protein	protein	NN	I-NP
O	735	741	kinase	kinase	NN	I-NP
O	742	746	that	that	WDT	B-NP
O	747	761	phosphorylates	phosphorylate	VBZ	B-VP
O	762	764	on	on	IN	B-PP
O	765	773	tyrosine	tyrosine	NN	B-NP
O	774	782	residues	residue	NNS	I-NP
O	782	783	.	.	.	O

O	784	786	We	We	PRP	B-NP
O	787	791	have	have	VBP	B-VP
O	792	800	examined	examine	VBN	I-VP
O	801	804	the	the	DT	B-NP
O	805	813	tyrosine	tyrosine	NN	I-NP
O	814	829	phosphorylation	phosphorylation	NN	I-NP
O	830	832	of	of	IN	B-PP
O	833	834	a	a	DT	B-NP
O	835	840	major	major	JJ	I-NP
B-Cell	841	849	cellular	cellular	JJ	I-NP
O	850	857	protein	protein	NN	I-NP
O	858	860	of	of	IN	B-PP
O	861	863	Mr	Mr	NN	B-NP
O	864	866	36	36	CD	I-NP
O	866	867	,	,	,	I-NP
O	867	870	000	000	CD	I-NP
O	871	873	in	in	IN	B-PP
B-Cell	874	879	cells	cell	NNS	B-NP
O	880	888	infected	infect	VBN	B-VP
O	889	893	with	with	IN	B-PP
O	894	895	a	a	DT	B-NP
O	896	901	panel	panel	NN	I-NP
O	902	904	of	of	IN	B-PP
O	905	914	partially	partially	RB	B-VP
O	915	927	transforming	transform	VBG	I-VP
O	928	935	mutants	mutant	NNS	B-NP
O	936	938	of	of	IN	B-PP
O	939	943	Rous	Rous	NNP	B-NP
O	944	951	sarcoma	sarcoma	NN	I-NP
O	952	957	virus	virus	NN	I-NP
O	957	958	.	.	.	O

O	959	962	One	One	CD	B-NP
O	963	965	of	of	IN	B-PP
O	966	971	these	these	DT	B-NP
O	972	979	mutants	mutant	NNS	I-NP
O	980	981	(	(	(	O
O	981	984	CU2	CU2	NN	B-NP
O	984	985	)	)	)	O
O	986	995	increases	increase	VBZ	B-VP
O	996	999	the	the	DT	B-NP
O	1000	1004	rate	rate	NN	I-NP
O	1005	1007	of	of	IN	B-PP
O	1008	1015	glucose	glucose	NN	B-NP
O	1016	1025	transport	transport	NN	I-NP
O	1026	1030	only	only	RB	B-ADVP
O	1031	1039	slightly	slightly	RB	I-ADVP
O	1040	1043	and	and	CC	O
O	1044	1048	does	do	VBZ	B-VP
O	1049	1052	not	not	RB	I-VP
O	1053	1059	render	render	VB	I-VP
O	1060	1063	the	the	DT	B-NP
O	1064	1072	infected	infected	JJ	I-NP
B-Cell	1073	1078	cells	cell	NNS	I-NP
O	1079	1084	fully	fully	RB	B-VP
O	1085	1094	anchorage	anchorage	VBP	I-VP
O	1095	1106	independent	independent	JJ	B-ADJP
O	1107	1109	or	or	CC	I-ADJP
O	1110	1121	tumorigenic	tumorigenic	JJ	I-ADJP
O	1122	1123	(	(	(	O
O	1123	1131	although	although	IN	B-SBAR
O	1132	1137	other	other	JJ	B-NP
O	1138	1152	transformation	transformation	NN	I-NP
O	1153	1163	parameters	parameter	NNS	I-NP
O	1164	1167	are	be	VBP	B-VP
O	1168	1173	fully	fully	RB	I-VP
O	1174	1181	induced	induce	VBN	I-VP
O	1181	1182	)	)	)	O
O	1182	1183	.	.	.	O

B-Cell	1184	1189	Cells	Cell	NNS	B-NP
O	1190	1198	infected	infect	VBN	B-VP
O	1199	1203	with	with	IN	B-PP
O	1204	1208	this	this	DT	B-NP
O	1209	1215	mutant	mutant	JJ	I-NP
O	1216	1223	display	display	NN	I-NP
O	1224	1225	a	a	DT	B-NP
O	1226	1228	36	36	CD	I-NP
O	1228	1229	,	,	,	I-NP
O	1229	1232	000	000	CD	I-NP
O	1232	1233	-	-	HYPH	I-NP
O	1233	1239	dalton	dalton	NN	I-NP
O	1240	1247	protein	protein	NN	I-NP
O	1248	1252	that	that	WDT	B-NP
O	1253	1255	is	be	VBZ	B-VP
O	1256	1270	phosphorylated	phosphorylate	VBN	I-VP
O	1271	1273	to	to	TO	B-PP
O	1274	1275	a	a	DT	B-NP
O	1276	1288	considerably	considerably	RB	I-NP
O	1289	1295	lesser	less	JJR	I-NP
O	1296	1302	extent	extent	NN	I-NP
O	1303	1307	than	than	IN	B-PP
B-Cell	1308	1313	cells	cell	NNS	B-NP
O	1314	1322	infected	infect	VBN	B-VP
O	1323	1327	with	with	IN	B-PP
O	1328	1332	wild	wild	JJ	B-NP
O	1332	1333	-	-	HYPH	I-NP
O	1333	1337	type	type	NN	I-NP
O	1338	1343	virus	virus	NN	I-NP
O	1343	1344	.	.	.	O

O	1345	1353	Analyses	Analysis	NNS	B-NP
O	1354	1356	of	of	IN	B-PP
O	1357	1361	this	this	DT	B-NP
O	1362	1366	sort	sort	NN	I-NP
O	1367	1370	may	may	MD	B-VP
O	1371	1375	help	help	VB	I-VP
O	1376	1378	to	to	TO	I-VP
O	1379	1387	identify	identify	VB	I-VP
O	1388	1391	the	the	DT	B-NP
B-Cell	1392	1400	cellular	cellular	JJ	I-NP
O	1401	1408	targets	target	NNS	I-NP
O	1409	1411	of	of	IN	B-PP
O	1412	1419	pp60src	pp60src	NN	B-NP
O	1420	1425	whose	whose	WP$	B-NP
O	1426	1441	phosphorylation	phosphorylation	NN	I-NP
O	1442	1444	is	be	VBZ	B-VP
O	1445	1454	necessary	necessary	JJ	B-ADJP
O	1455	1458	for	for	IN	B-PP
O	1459	1462	the	the	DT	B-NP
O	1463	1472	increased	increase	VBN	I-NP
O	1473	1480	glucose	glucose	NN	I-NP
O	1481	1490	transport	transport	NN	I-NP
O	1491	1495	rate	rate	NN	I-NP
O	1495	1496	.	.	.	O

